Back to funds
View filing
Commodore Capital LP
Updated 6 days agoManaged by Commodore Capital Lp • Latest filing Q3 2026
Portfolio value
$1.3B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $1.5B |
| Q1 2026 | $1.7B |
| Q2 2026 | $1.7B |
| Q3 2026 | $1.3B |
Top holdings
37 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $216.6M | 12.00M | 16.78% | — | |
| 2 | $150.1M | 3.27M | 11.63% | — | |
| 3 | $116.5M | 2.88M | 9.03% | — | |
| 4 | $69.5M | 2.72M | 5.39% | — | |
| 5 | $62.3M | 700.0K | 4.83% | — | |
| 6 | $58.2M | 2.00M | 4.51% | — | |
| 7 | $49.2M | 1.28M | 3.81% | — | |
| 8 | ? N/A DAMORA THERAPEUTICS INC | $41.3M | 1.94M | 3.20% | — |
| 9 | $40.5M | 1.26M | 3.14% | — | |
| 10 | $37.7M | 1.73M | 2.92% | — | |
| 11 | $32.4M | 1.00M | 2.51% | — | |
| 12 | $29.3M | 925.0K | 2.27% | — | |
| 13 | ? N/A SURROZEN INC | $28.5M | 885.0K | 2.21% | — |
| 14 | $28.1M | 877.0K | 2.17% | — | |
| 15 | $27.2M | 2.76M | 2.11% | — | |
| 16 | $26.6M | 700.0K | 2.06% | — | |
| 17 | $25.1M | 1.26M | 1.95% | — | |
| 18 | $22.8M | 8.89M | 1.77% | — | |
| 19 | $21.4M | 7.35M | 1.66% | — | |
| 20 | ? N/A ATTOVIA THERAPEUTICS INC | $19.9M | 1.16M | 1.54% | — |